|
Авторизація
|
Основні захворювання та їх поширення у Європі (DISEASE INCIDENCE & PREVALENCE STATISTICS IN EUROPE: FRANCE, GERMANY, SPAIN, ITALY & UK) Оскільки старіння населення Європи збільшується, а середня тривалість життя подовжується, поширення основних захворювань/порушень, як очікується, значно вплине на європейську індустрію охорони здоров'я. Даний звіт включає в себе серію з п'яти доповідей (захворювань та їх поширення у Франції, Німеччині, Італії, Іспанії та Великобританії), в яких розглядаються питання етіології та епідеміології з найбільш поширених і дорогих захворювань/порушень в Європі.
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/ disorders in France, Germany, Italy, Spain, and the United Kingdom and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom).
This report includes a series of five reports (Disease Incidence and Prevalence for France, Germany, Italy, Spain, and the United Kingdom) that examine the etiology and epidemiology of the most prevalent and costly diseases/disorders in Europe. Topics covered by each of these reports include Alzheimer's disease, anemia, arthritis, asthma, benign prostatic hyperplasia, bronchitis, burns/traumatic wounds, cancer, depression, diabetes, emphysema, erectile dysfunction, glaucoma, heart failure, human immunodeficiency virus/acquired immune deficiency syndrome, hypertension, infertility, multiple sclerosis, osteoporosis, pneumonia, stroke, and transmissible spongiform encephalopathies, among others. In addition to proprietary data utilized from Medtech Insight's internal resources, many agencies and organizations have provided information including Alzheimer's Disease International, Association France Parkinson, Cystic Fibrosis Europe, European Association of Urology, European Cancer Observatory, European Centre for Disease Prevention and Control, European Society of Cardiology, French Cystic Fibrosis Association, French Society for Research and Sleep Medicine, International Diabetes Federation, International Osteoporosis Foundation, Multiple Sclerosis International Federation, Myasthenia Gravis Association, Organization for Economic Cooperation and Development, and the World Health Organization, among others. France INTRODUCTION 1. EUROPEAN HEALTHCARE OVERVIEW 1.1 Healthcare Spending 1.2 Healthcare Facilities and Providers 1.3 Reimbursement Structures and Common Market Directives 1.4 Selected National Healthcare Profiles for France 1.4.1 Healthcare Organization and ReformExhibit 1-1: European Healthcare Expenditures as a Percentage of Gross Domestic Product, Selected Countries, 2002-2008 Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020 Exhibit 1-3: Classification of European Healthcare Providers Exhibit 1-4: Healthcare Providers within the European Economy Exhibit 1-5: Average Hospital Length of Stay, Acute Care, Selected Countries, 2002-2008 Exhibit 1-6: European Union, Medical Devices Risk Classification System Exhibit 1-7: France, Selected National Healthcare Statistics 2. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA 2.1 Anemia 2.1.1 Iron Deficiency Anemia2.2 Hemophilia 2.2.1 EtiologyExhibit 2-1: Europe, Estimated Prevalence of Anemia, by Age and Gender Exhibit 2-2: France and Europe, Iron Deficiency Anemia, Comparative Incidence and Prevalence Exhibit 2-3: France and Europe, Sickle Cell Anemia, Comparative Incidence and Prevalence Exhibit 2-4: France and Europe, Thalassemia, Comparative Prevalence Exhibit 2-5: France and Europe, Hemophilia, Comparative Incidence and Prevalence 3. CANCER 3.1 Bladder Cancer 3.1.1 Etiology3.2 Brain Tumors 3.2.1 Etiology3.3 Breast Cancer 3.3.1 Etiology3.4 Cervical/Uterine Cancer 3.4.1 Etiology3.5 Colon/Rectal Cancer 3.5.1 Etiology3.6 Esophageal Cancer 3.6.1 Etiology3.7 Kidney/Urothelial Cancer 3.7.1 Etiology3.8 Leukemia 3.8.1 Etiology3.9 Lung Cancer 3.9.1 Etiology3.10 Lymphoma 3.10.1 Etiology3.11 Melanoma 3.11.1 Etiology3.12 Oral Cancer 3.12.1 Etiology3.13 Ovarian Cancer 3.13.1 Etiology3.14 Pancreatic Cancer 3.14.1 Etiology3.15 Prostate Cancer 3.15.1 Etiology3.16 Stomach Cancer 3.16.1 Etiology3.17 Testicular Cancer 3.17.1 EtiologyExhibit 3-1: France and Europe, Bladder Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-2: France and Europe, Brain Tumors, Comparative Incidence, by Gender Exhibit 3-3: France and Europe, Breast Cancer, Comparative Incidence and Mortality Exhibit 3-4: France and Europe, Cervical/Uterine Cancer, Comparative Incidence and Mortality Exhibit 3-5: France and Europe, Colon/Rectal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-6: France and Europe, Esophageal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-7: France and Europe, Kidney/Urothelial Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-8: France and Europe, Leukemia, Comparative Incidence and Mortality, by Gender Exhibit 3-9: France and Europe, Lung Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-10: France and Europe, Lymphoma, Comparative Incidence and Mortality, by Gender Exhibit 3-11: France and Europe, Melanoma, Comparative Incidence and Mortality, by Gender Exhibit 3-12: France and Europe, Oral Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-13: France and Europe, Ovarian Cancer, Comparative Incidence and Mortality Exhibit 3-14: France and Europe, Pancreatic Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-15: France and Europe, Prostate Cancer, Comparative Incidence and Mortality Exhibit 3-16: France and Europe, Stomach Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-17: France and Europe, Testicular Cancer, Comparative Incidence and Mortality 4. CARDIOVASCULAR DISORDERS 4.1 Cardiac Arrhythmia 4.1.1 Etiology4.2 Heart Failure 4.2.1 Etiology4.3 Heart Valve Disorders 4.3.1 Etiology4.4 Hypertension 4.4.1 Etiology4.5 Vascular Disorders 4.5.1 AneurysmsExhibit 4-1: France and Europe, Atrial Fibrillation, Comparative Incidence and Prevalence Exhibit 4-2: France and Europe, Atrial Flutter, Comparative Incidence and Prevalence Exhibit 4-3: France and Europe, Supraventricular Tachycardia, Comparative Incidence and Prevalence Exhibit 4-4: France and Europe, Heart Failure, Comparative Incidence and Prevalence, by Gender Exhibit 4-5: France and Europe, Heart Valve Disorders, Comparative Incidence and Prevalence, by Gender Exhibit 4-6: France and Europe, Hypertension, Comparative Incidence and Prevalence Exhibit 4-7: France and Europe, Aneurysms, Comparative Incidence and Prevalence Exhibit 4-8: Standard Angina Pectoris Classification Exhibit 4-9: France and Europe, Angina Pectoris, Comparative Incidence and Prevalence, by Gender Exhibit 4-10: France and Europe, Hypercholesteremia, Comparative Prevalence, by Gender and Selected Country Exhibit 4-11: France and Europe, Myocardial Infarction, Comparative Incidence and Prevalence, by Gender Exhibit 4-12: France and Europe, Peripheral Vascular Disease, Comparative Incidence and Prevalence 5. METABOLIC DISORDERS 5.1 Cholelithiasis 5.1.1 Etiology5.2 Chronic Kidney Disease/End-Stage Renal Disease 5.2.1 Etiology5.3 Diabetes 5.3.1 Etiology5.4 Urolithiasis 5.4.1 EtiologyExhibit 5-1: France and Europe, Cholelithiasis, Comparative Incidence and Prevalence Exhibit 5-2: France and Europe, Chronic Kidney Disease, Comparative Incidence and Prevalence, by Gender Exhibit 5-3: France and Europe, Diabetes, Comparative Incidence, by Gender Exhibit 5-4: France and Europe, Diabetes, Comparative Prevalence, by Share of Population Exhibit 5-5: France and Europe, Diabetes, Comparative Prevalence, by Gender and Age Group Exhibit 5-6: France and Europe, Urolithiasis, Comparative Incidence and Prevalence 6. MUSCULOSKELETAL DISORDERS 6.1 Arthritis 6.1.1 Etiology6.2 Carpal Tunnel Syndrome 6.2.1 Etiology6.3 Meniscal and Ligament/Tendon Injuries 6.3.1 Etiology6.4 Duchenne Muscular Dystrophy 6.4.1 Etiology6.5 Osteoporosis 6.5.1 EtiologyExhibit 6-1: France and Europe, Rheumatoid Arthritis, Comparative Incidence and Prevalence Exhibit 6-2: France and Europe, Osteoarthritis of the Knee, Comparative Incidence and Prevalence Exhibit 6-3: France and Europe, Osteoarthritis of the Hip, Comparative Incidence and Prevalence Exhibit 6-4: France and Europe, Carpal Tunnel Syndrome, Comparative Incidence and Prevalence Exhibit 6-5: France and Europe, Meniscal and Ligament/Tendon Injuries of the Knee, Comparative Incidence and Prevalence Exhibit 6-6: France and Europe, Duchenne Muscular Dystrophy, Comparative Incidence and Prevalence Exhibit 6-7: France and Europe, Osteoporosis, Comparative Incidence and Prevalence 7. NEUROLOGIC ANDPSYCHIATRIC DISORDERS 7.1 Alzheimer's Disease and Dementia 7.1.1 Etiology7.2 Amyotrophic Lateral Sclerosis 7.2.1 Etiology7.3 Bipolar Disorder 7.3.1 Etiology7.4 Cerebrovascular Disorders 7.4.1 Arteriovenous Malformation7.5 Depression 7.5.1 Etiology7.6 Epilepsy 7.6.1 Etiology7.7 Huntington's Disease 7.7.1 Etiology7.8 Hydrocephalus 7.8.1 Etiology7.9 Multiple Sclerosis 7.9.1 Etiology7.10 Myasthenia Gravis 7.10.1 Etiology7.11 Parkinson's Disease 7.11.1 Etiology7.12 Schizophrenia 7.12.1 EtiologyExhibit 7-1: 2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender Exhibit 7-2: 2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender Exhibit 7-3: France and Europe, Alzheimer's Disease, Comparative Incidence and Prevalence Exhibit 7-4: France and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence Exhibit 7-5: France and Europe, Bipolar Disorder, Comparative Incidence and Prevalence Exhibit 7-6: France and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence Exhibit 7-7: France and Europe, Stroke, Comparative Incidence and Prevalence Exhibit 7-8: France and Europe, Depression, Comparative Prevalence Exhibit 7-9: France and Europe, Epilepsy, Comparative Incidence and Prevalence Exhibit 7-10: France and Europe, Huntington's Disease, Comparative Incidence and Prevalence Exhibit 7-11: France and Europe, Hydrocephalus, Comparative Incidence and Prevalence Exhibit 7-12: France and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence Exhibit 7-13: France and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence Exhibit 7-14: France and Europe, Parkinson's Disease, Comparative Incidence and Prevalence Exhibit 7-15: France and Europe, Schizophrenia, Comparative Incidence and Prevalence 8. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA 8.1 Cataracts 8.1.1 Etiology8.2 Glaucoma 8.2.1 EtiologyExhibit 8-1: France and Europe, Cataracts, Comparative Incidence and Prevalence Exhibit 8-2: France and Europe, Glaucoma, Comparative Incidence and Prevalence 9. REPRODUCTIVE AND GENITOURINARY DISORDERS 9.1 Benign Prostatic Hyperplasia 9.1.1 Etiology9.2 Endometriosis 9.2.1 Etiology9.3 Erectile Dysfunction 9.3.1 Etiology9.4 Infertility 9.4.1 Etiology9.5 Urinary Incontinence 9.5.1 EtiologyExhibit 9-1: 2010, Europe, Benign Prostatic Hyperplasia, Incidence, by Age Exhibit 9-2: France and Europe, Benign Prostatic Hyperplasia, Comparative Incidence and Prevalence Exhibit 9-3: France and Europe, Endometriosis, Comparative Prevalence Exhibit 9-4: France and Europe, Erectile Dysfunction, Comparative Incidence and Prevalence Exhibit 9-5: France and Europe, Infertility, Comparative Incidence and Prevalence Exhibit 9-6: France and Europe, Urinary Incontinence, Comparative Incidence and Prevalence 10. RESPIRATORY DISORDERS 10.1 Acute Respiratory Distress Syndrome 10.1.1 Etiology10.2 Apnea 10.2.1 Etiology10.3 Asthma 10.3.1 Etiology10.4 Cystic Fibrosis 10.4.1 Etiology10.5 Emphysema 10.5.1 Etiology10.6 Pneumothorax 10.6.1 Etiology10.7 Respiratory Failure 10.7.1 Etiology10.8 Restrictive Lung Disease 10.8.1 EtiologyExhibit 10-1: France and Europe, Acute Respiratory Distress Syndrome, Comparative Incidence Exhibit 10-2: France and Europe, Apnea, Comparative Incidence and Prevalence Exhibit 10-3: France and Europe, Asthma, Comparative Incidence and Prevalence Exhibit 10-4: France and Europe, Cystic Fibrosis, Comparative Incidence and Prevalence Exhibit 10-5: France and Europe, Emphysema, Comparative Prevalence Exhibit 10-6: France and Europe, Pneumothorax, Comparative Incidence and Prevalence Exhibit 10-7: France and Europe, Respiratory Failure, Comparative Incidence and Prevalence Exhibit 10-8: France and Europe, Restrictive Lung Disease, Comparative Incidence and Prevalence 11. WOUNDS 11.1 Diabetic Ulcers 11.1.1 Etiology11.2 Pressure Ulcers 11.2.1 Etiology11.3 Surgical Wounds 11.3.1 Etiology11.4 Traumatic Wounds 11.4.1 BurnsExhibit 11-1: France and Europe, Diabetic Ulcers, Comparative Incidence and Prevalence Exhibit 11-2: France and Europe, Pressure Ulcers, Comparative Incidence and Prevalence Exhibit 11-3: France and Europe, Surgical Wounds, Comparative Incidence Exhibit 11-4: Classification of Burns, by Mechanism of Injury Exhibit 11-5: France and Europe, Burns and Acute Traumatic Injury, Comparative Incidence 12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS 12.1 Chronic Bronchitis 12.1.1 Etiology12.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 12.2.1 Etiology12.3 Pneumonia 12.3.1 Etiology12.4 Transmissible Spongiform Encephalopathies 12.4.1 Etiology12.5 Tuberculosis 12.5.1 EtiologyExhibit 12-1: France and Europe, Chronic Bronchitis, Comparative Prevalence Exhibit 12-2: Acquired Immune Deficiency Syndrome, Indicator Diseases Exhibit 12-3: France and Europe, Human Immunodeficiency Virus, Comparative Incidence and Prevalence Exhibit 12-4: France and Europe, Acquired Immune Deficiency Syndrome, Comparative Incidence and Prevalence Exhibit 12-5: France and Europe, Pneumonia, Comparative Incidence Exhibit 12-6: France and Europe, Transmissible Spongiform Encephalopathies, Comparative Incidence Exhibit 12-7: France and Europe, Tuberculosis, Comparative Incidence and Prevalence Germany INTRODUCTION 1. EUROPEAN HEALTHCARE OVERVIEW 1.1 Healthcare Spending 1.2 Healthcare Facilities and Providers 1.3 Reimbursement Structures and Common Market Directives 1.4 Selected National Healthcare Profiles for Germany 1.4.1 Healthcare Organization and ReformExhibit 1-1: European Healthcare Expenditures as a Percentage of Gross Domestic Product, Selected Countries, 2002-2008 Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020 Exhibit 1-3: Classification of European Healthcare Providers Exhibit 1-4: Healthcare Providers within the European Economy Exhibit 1-5: Average Hospital Length of Stay, Acute Care, Selected Countries, 2002-2008 Exhibit 1-6: European Union, Medical Devices Risk Classification System Exhibit 1-7: Germany, Selected National Healthcare Statistics 2. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA 2.1 Anemia 2.1.1 Iron Deficiency Anemia2.1.3 Thalassemia 2.1.3.1 Etiology2.2 Hemophilia 2.2.1 EtiologyExhibit 2-1: Europe, Estimated Prevalence of Anemia, by Age and Gender Exhibit 2-2: Germany and Europe, Iron Deficiency Anemia, Comparative Incidence and Prevalence Exhibit 2-3: Germany and Europe, Sickle Cell Anemia, Comparative Incidence and Prevalence Exhibit 2-4: Germany and Europe, Thalassemia, Comparative Prevalence Exhibit 2-5: Germany and Europe, Hemophilia, Comparative Incidence and Prevalence 3. CANCER 3.1 Bladder Cancer 3.1.1 Etiology3.2 Brain Tumors 3.2.1 Etiology3.3 Breast Cancer 3.3.1 Etiology3.4 Cervical/Uterine Cancer 3.4.1 Etiology3.5 Colon/Rectal Cancer 3.5.1 Etiology3.6 Esophageal Cancer 3.6.1 Etiology3.7 Kidney/Urothelial Cancer 3.7.1 Etiology3.8 Leukemia 3.8.1 Etiology3.9 Lung Cancer 3.9.1 Etiology3.10 Lymphoma 3.10.1 Etiology3.11 Melanoma 3.11.1 Etiology3.12 Oral Cancer 3.12.1 Etiology3.13 Ovarian Cancer 3.13.1 Etiology3.14 Pancreatic Cancer 3.14.1 Etiology3.15 Prostate Cancer 3.15.1 Etiology3.16 Stomach Cancer 3.16.1 Etiology3.17 Testicular Cancer 3.17.1 EtiologyExhibit 3-1: Germany and Europe, Bladder Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-2: Germany and Europe, Brain Tumors, Comparative Incidence, by Gender Exhibit 3-3: Germany and Europe, Breast Cancer, Comparative Incidence and Mortality Exhibit 3-4: Germany and Europe, Cervical/Uterine Cancer, Comparative Incidence and Mortality Exhibit 3-5: Germany and Europe, Colon/Rectal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-6: Germany and Europe, Esophageal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-7: Germany and Europe, Kidney/Urothelial Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-8: Germany and Europe, Leukemia, Comparative Incidence and Mortality, by Gender Exhibit 3-9: Germany and Europe, Lung Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-10: Germany and Europe, Lymphoma, Comparative Incidence and Mortality, by Gender Exhibit 3-11: Germany and Europe, Melanoma, Comparative Incidence and Mortality, by Gender Exhibit 3-12: Germany and Europe, Oral Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-13: Germany and Europe, Ovarian Cancer, Comparative Incidence and Mortality Exhibit 3-14: Germany and Europe, Pancreatic Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-15: Germany and Europe, Prostate Cancer, Comparative Incidence and Mortality Exhibit 3-16: Germany and Europe, Stomach Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-17: Germany and Europe, Testicular Cancer, Comparative Incidence and Mortality 4. CARDIOVASCULAR DISORDERS 4.1 Cardiac Arrhythmia 4.1.1 Etiology4.2 Heart Failure 4.2.1 Etiology4.3 Heart Valve Disorders 4.3.1 Etiology4.4 Hypertension 4.4.1 Etiology4.5 Vascular Disorders 4.5.1 AneurysmsExhibit 4-1: Germany and Europe, Atrial Fibrillation, Comparative Incidence and Prevalence Exhibit 4-2: Germany and Europe, Atrial Flutter, Comparative Incidence and Prevalence Exhibit 4-3: Germany and Europe, Supraventricular Tachycardia, Comparative Incidence and Prevalence Exhibit 4-4: Germany and Europe, Heart Failure, Comparative Incidence and Prevalence, by Gender Exhibit 4-5: Germany and Europe, Heart Valve Disorders, Comparative Incidence and Prevalence, by Gender Exhibit 4-6: Germany and Europe, Hypertension, Comparative Incidence and Prevalence Exhibit 4-7: Germany and Europe, Aneurysms, Comparative Incidence and Prevalence Exhibit 4-8: Standard Angina Pectoris Classification Exhibit 4-9: Germany and Europe, Angina Pectoris, Comparative Incidence and Prevalence, by Gender Exhibit 4-10: Germany and Europe, Hypercholesteremia, Comparative Prevalence, by Gender and Selected Country Exhibit 4-11: Germany and Europe, Myocardial Infarction, Comparative Incidence and Prevalence, by Gender Exhibit 4-12: Germany and Europe, Peripheral Vascular Disease, Comparative Incidence and Prevalence 5. METABOLIC DISORDERS 5.1 Cholelithiasis 5.1.1 Etiology5.2 Chronic Kidney Disease/End-Stage Renal Disease 5.2.1 Etiology5.3 Diabetes 5.3.1 Etiology5.4 Urolithiasis 5.4.1 EtiologyExhibit 5-1: Germany and Europe, Cholelithiasis, Comparative Incidence and Prevalence Exhibit 5-2: Germany and Europe, Chronic Kidney Disease, Comparative Incidence and Prevalence, by Gender Exhibit 5-3: Germany and Europe, Diabetes, Comparative Incidence, by Gender Exhibit 5-4: Germany and Europe, Diabetes, Comparative Prevalence, by Share of Population Exhibit 5-5: Germany and Europe, Diabetes, Comparative Prevalence, by Gender and Age Group Exhibit 5-6: Germany and Europe, Urolithiasis, Comparative Incidence and Prevalence 6. MUSCULOSKELETAL DISORDERS 6.1 Arthritis 6.1.1 Etiology6.2 Carpal Tunnel Syndrome 6.2.1 Etiology6.3 Meniscal and Ligament/Tendon Injuries 6.3.1 Etiology6.4 Duchenne Muscular Dystrophy 6.4.1 Etiology6.5 Osteoporosis 6.5.1 EtiologyExhibit 6-1: Germany and Europe, Rheumatoid Arthritis, Comparative Incidence and Prevalence Exhibit 6-2: Germany and Europe, Osteoarthritis of the Knee, Comparative Incidence and Prevalence Exhibit 6-3: Germany and Europe, Osteoarthritis of the Hip, Comparative Incidence and Prevalence Exhibit 6-4: Germany and Europe, Carpal Tunnel Syndrome, Comparative Incidence and Prevalence Exhibit 6-5: Germany and Europe, Meniscal and Ligament/Tendon Injuries of the Knee, Comparative Incidence and Prevalence Exhibit 6-6: Germany and Europe, Duchenne Muscular Dystrophy, Comparative Incidence and Prevalence Exhibit 6-7: Germany and Europe, Osteoporosis, Comparative Incidence and Prevalence 7. NEUROLOGIC ANDPSYCHIATRIC DISORDERS 7.1 Alzheimer's Disease and Dementia 7.1.1 Etiology7.2 Amyotrophic Lateral Sclerosis 7.2.1 Etiology7.3 Bipolar Disorder 7.3.1 Etiology7.4 Cerebrovascular Disorders 7.4.1 Arteriovenous Malformation7.5 Depression 7.5.1 Etiology7.6 Epilepsy 7.6.1 Etiology7.7 Huntington's Disease 7.7.1 Etiology7.8 Hydrocephalus 7.8.1 Etiology7.9 Multiple Sclerosis 7.9.1 Etiology7.10 Myasthenia Gravis 7.10.1 Etiology7.11 Parkinson's Disease 7.11.1 Etiology7.12 Schizophrenia 7.12.1 EtiologyExhibit 7-1: 2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender Exhibit 7-2: 2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender Exhibit 7-3: Germany and Europe, Alzheimer's Disease, Comparative Incidence and Prevalence Exhibit 7-4: Germany and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence Exhibit 7-5: Germany and Europe, Bipolar Disorder, Comparative Incidence and Prevalence Exhibit 7-6: Germany and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence Exhibit 7-7: Germany and Europe, Stroke, Comparative Incidence and Prevalence Exhibit 7-8: Germany and Europe, Depression, Comparative Prevalence Exhibit 7-9: Germany and Europe, Epilepsy, Comparative Incidence and Prevalence Exhibit 7-10: Germany and Europe, Huntington's Disease, Comparative Incidence and Prevalence Exhibit 7-11: Germany and Europe, Hydrocephalus, Comparative Incidence and Prevalence Exhibit 7-12: Germany and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence Exhibit 7-13: Germany and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence Exhibit 7-14: Germany and Europe, Parkinson's Disease, Comparative Incidence and Prevalence Exhibit 7-15: Germany and Europe, Schizophrenia, Comparative Incidence and Prevalence 8. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA 8.1 Cataracts 8.1.1 Etiology8.2 Glaucoma 8.2.1 EtiologyExhibit 8-1: Germany and Europe, Cataracts, Comparative Incidence and Prevalence Exhibit 8-2: Germany and Europe, Glaucoma, Comparative Incidence and Prevalence 9. REPRODUCTIVE AND GENITOURINARY DISORDERS 9.1 Benign Prostatic Hyperplasia 9.1.1 Etiology9.2 Endometriosis 9.2.1 Etiology9.3 Erectile Dysfunction 9.3.1 Etiology9.4 Infertility 9.4.1 Etiology9.5 Urinary Incontinence 9.5.1 EtiologyExhibit 9-1: 2010, Europe, Benign Prostatic Hyperplasia, Incidence, by Age Exhibit 9-2: Germany and Europe, Benign Prostatic Hyperplasia, Comparative Incidence and Prevalence Exhibit 9-3: Germany and Europe, Endometriosis, Comparative Prevalence Exhibit 9-4: Germany and Europe, Erectile Dysfunction, Comparative Incidence and Prevalence Exhibit 9-5: Germany and Europe, Infertility, Comparative Incidence and Prevalence Exhibit 9-6: Germany and Europe, Urinary Incontinence, Comparative Incidence and Prevalence 10. RESPIRATORY DISORDERS 10.1 Acute Respiratory Distress Syndrome 10.1.1 Etiology10.2 Apnea 10.2.1 Etiology10.3 Asthma 10.3.1 Etiology10.4 Cystic Fibrosis 10.4.1 Etiology10.5 Emphysema 10.5.1 Etiology10.6 Pneumothorax 10.6.1 Etiology10.7 Respiratory Failure 10.7.1 Etiology10.8 Restrictive Lung Disease 10.8.1 EtiologyExhibit 10-1: Germany and Europe, Acute Respiratory Distress Syndrome, Comparative Incidence Exhibit 10-2: Germany and Europe, Apnea, Comparative Incidence and Prevalence Exhibit 10-3: Germany and Europe, Asthma, Comparative Incidence and Prevalence Exhibit 10-4: Germany and Europe, Cystic Fibrosis, Comparative Incidence and Prevalence Exhibit 10-5: Germany and Europe, Emphysema, Comparative Prevalence Exhibit 10-6: Germany and Europe, Pneumothorax, Comparative Incidence and Prevalence Exhibit 10-7: Germany and Europe, Respiratory Failure, Comparative Incidence and Prevalence Exhibit 10-8: Germany and Europe, Restrictive Lung Disease, Comparative Incidence and Prevalence 11. WOUNDS 11.1 Diabetic Ulcers 11.1.1 Etiology11.2 Pressure Ulcers 11.2.1 Etiology11.3 Surgical Wounds 11.3.1 Etiology11.4 Traumatic Wounds 11.4.1 BurnsExhibit 11-1: Germany and Europe, Diabetic Ulcers, Comparative Incidence and Prevalence Exhibit 11-2: Germany and Europe, Pressure Ulcers, Comparative Incidence and Prevalence Exhibit 11-3: Germany and Europe, Surgical Wounds, Comparative Incidence Exhibit 11-4: Classification of Burns, by Mechanism of Injury Exhibit 11-5: Germany and Europe, Burns and Acute Traumatic Injury, Comparative Incidence 12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS 12.1 Chronic Bronchitis 12.1.1 Etiology12.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 12.2.1 Etiology12.3 Pneumonia 12.3.1 Etiology12.4 Transmissible Spongiform Encephalopathies 12.4.1 Etiology12.5 Tuberculosis 12.5.1 EtiologyExhibit 12-1: Germany and Europe, Chronic Bronchitis, Comparative Prevalence Exhibit 12-2: Acquired Immune Deficiency Syndrome, Indicator Diseases Exhibit 12-3: Germany and Europe, Human Immunodeficiency Virus, Comparative Incidence and Prevalence Exhibit 12-4: Germany and Europe, Acquired Immune Deficiency Syndrome, Comparative Incidence and Prevalence Exhibit 12-5: Germany and Europe, Pneumonia, Comparative Incidence Exhibit 12-6: Germany and Europe, Transmissible Spongiform Encephalopathies, Comparative Incidence Exhibit 12-7: Germany and Europe, Tuberculosis, Comparative Incidence and Prevalence Italy INTRODUCTION 1. EUROPEAN HEALTHCARE OVERVIEW 1.1 Healthcare Spending 1.2 Healthcare Facilities and Providers 1.3 Reimbursement Structures and Common Market Directives 1.4 Selected National Healthcare Profiles for Italy 1.4.1 Healthcare Organization and ReformExhibit 1-1: European Healthcare Expenditures as a Percentage of Gross Domestic Product, Selected Countries, 2002-2008 Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020 Exhibit 1-3: Classification of European Healthcare Providers Exhibit 1-4: Healthcare Providers within the European Economy Exhibit 1-5: Average Hospital Length of Stay, Acute Care, Selected Countries, 2002-2008 Exhibit 1-6: European Union, Medical Devices Risk Classification System Exhibit 1-7: Italy, Selected National Healthcare Statistics 2. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA 2.1 Anemia 2.1.1 Iron Deficiency Anemia2.2 Hemophilia 2.2.1 EtiologyExhibit 2-1: Europe, Estimated Prevalence of Anemia, by Age and Gender Exhibit 2-2: Italy and Europe, Iron Deficiency Anemia, Comparative Incidence and Prevalence Exhibit 2-3: Italy and Europe, Sickle Cell Anemia, Comparative Incidence and Prevalence Exhibit 2-4: Italy and Europe, Thalassemia, Comparative Prevalence Exhibit 2-5: Italy and Europe, Hemophilia, Comparative Incidence and Prevalence 3. CANCER 3.1 Bladder Cancer 3.1.1 Etiology3.2 Brain Tumors 3.2.1 Etiology3.3 Breast Cancer 3.3.1 Etiology3.4 Cervical/Uterine Cancer 3.4.1 Etiology3.5 Colon/Rectal Cancer 3.5.1 Etiology3.6 Esophageal Cancer 3.6.1 Etiology3.7 Kidney/Urothelial Cancer 3.7.1 Etiology3.8 Leukemia 3.8.1 Etiology3.9 Lung Cancer 3.9.1 Etiology3.10 Lymphoma 3.10.1 Etiology3.11 Melanoma 3.11.1 Etiology3.12 Oral Cancer 3.12.1 Etiology3.13 Ovarian Cancer 3.13.1 Etiology3.14 Pancreatic Cancer 3.14.1 Etiology3.15 Prostate Cancer 3.15.1 Etiology3.16 Stomach Cancer 3.16.1 Etiology3.17 Testicular Cancer 3.17.1 EtiologyExhibit 3-1: Italy and Europe, Bladder Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-2: Italy and Europe, Brain Tumors, Comparative Incidence, by Gender Exhibit 3-3: Italy and Europe, Breast Cancer, Comparative Incidence and Mortality Exhibit 3-4: Italy and Europe, Cervical/Uterine Cancer, Comparative Incidence and Mortality Exhibit 3-5: Italy and Europe, Colon/Rectal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-6: Italy and Europe, Esophageal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-7: Italy and Europe, Kidney/Urothelial Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-8: Italy and Europe, Leukemia, Comparative Incidence and Mortality, by Gender Exhibit 3-9: Italy and Europe, Lung Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-10: Italy and Europe, Lymphoma, Comparative Incidence and Mortality, by Gender Exhibit 3-11: Italy and Europe, Melanoma, Comparative Incidence and Mortality, by Gender Exhibit 3-12: Italy and Europe, Oral Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-13: Italy and Europe, Ovarian Cancer, Comparative Incidence and Mortality Exhibit 3-14: Italy and Europe, Pancreatic Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-15: Italy and Europe, Prostate Cancer, Comparative Incidence and Mortality Exhibit 3-16: Italy and Europe, Stomach Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-17: Italy and Europe, Testicular Cancer, Comparative Incidence and Mortality 4. CARDIOVASCULAR DISORDERS 4.1 Cardiac Arrhythmia 4.1.1 Etiology4.2 Heart Failure 4.2.1 Etiology4.3 Heart Valve Disorders 4.3.1 Etiology4.4 Hypertension 4.4.1 Etiology4.5 Vascular Disorders 4.5.1 AneurysmsExhibit 4-1: Italy and Europe, Atrial Fibrillation, Comparative Incidence and Prevalence Exhibit 4-2: Italy and Europe, Atrial Flutter, Comparative Incidence and Prevalence Exhibit 4-3: Italy and Europe, Supraventricular Tachycardia, Comparative Incidence and Prevalence Exhibit 4-4: Italy and Europe, Heart Failure, Comparative Incidence and Prevalence, by Gender Exhibit 4-5: Italy and Europe, Heart Valve Disorders, Comparative Incidence and Prevalence, by Gender Exhibit 4-6: Italy and Europe, Hypertension, Comparative Incidence and Prevalence Exhibit 4-7: Italy and Europe, Aneurysms, Comparative Incidence and Prevalence Exhibit 4-8: Standard Angina Pectoris Classification Exhibit 4-9: Italy and Europe, Angina Pectoris, Comparative Incidence and Prevalence, by Gender Exhibit 4-10: Italy and Europe, Hypercholesteremia, Comparative Prevalence, by Gender and Selected Country Exhibit 4-11: Italy and Europe, Myocardial Infarction, Comparative Incidence and Prevalence, by Gender Exhibit 4-12: Italy and Europe, Peripheral Vascular Disease, Comparative Incidence and Prevalence 5. METABOLIC DISORDERS 5.1 Cholelithiasis 5.1.1 Etiology5.2 Chronic Kidney Disease/End-Stage Renal Disease 5.2.1 Etiology5.3 Diabetes 5.3.1 Etiology5.4 Urolithiasis 5.4.1 EtiologyExhibit 5-1: Italy and Europe, Cholelithiasis, Comparative Incidence and Prevalence Exhibit 5-2: Italy and Europe, Chronic Kidney Disease, Comparative Incidence and Prevalence, by Gender Exhibit 5-3: Italy and Europe, Diabetes, Comparative Incidence, by Gender Exhibit 5-4: Italy and Europe, Diabetes, Comparative Prevalence, by Share of Population Exhibit 5-5: Italy and Europe, Diabetes, Comparative Prevalence, by Gender and Age Group Exhibit 5-6: Italy and Europe, Urolithiasis, Comparative Incidence and Prevalence 6. MUSCULOSKELETAL DISORDERS 6.1 Arthritis 6.1.1 Etiology6.2 Carpal Tunnel Syndrome 6.2.1 Etiology6.3 Meniscal and Ligament/Tendon Injuries 6.3.1 Etiology6.4 Duchenne Muscular Dystrophy 6.4.1 Etiology6.5 Osteoporosis 6.5.1 EtiologyExhibit 6-1: Italy and Europe, Rheumatoid Arthritis, Comparative Incidence and Prevalence Exhibit 6-2: Italy and Europe, Osteoarthritis of the Knee, Comparative Incidence and Prevalence Exhibit 6-3: Italy and Europe, Osteoarthritis of the Hip, Comparative Incidence and Prevalence Exhibit 6-4: Italy and Europe, Carpal Tunnel Syndrome, Comparative Incidence and Prevalence Exhibit 6-5: Italy and Europe, Meniscal and Ligament/Tendon Injuries of the Knee, Comparative Incidence and Prevalence Exhibit 6-6: Italy and Europe, Duchenne Muscular Dystrophy, Comparative Incidence and Prevalence Exhibit 6-7: Italy and Europe, Osteoporosis, Comparative Incidence and Prevalence 7. NEUROLOGIC ANDPSYCHIATRIC DISORDERS 7.1 Alzheimer's Disease and Dementia 7.1.1 Etiology7.2 Amyotrophic Lateral Sclerosis 7.2.1 Etiology7.3 Bipolar Disorder 7.3.1 Etiology7.4 Cerebrovascular Disorders 7.4.1 Arteriovenous Malformation7.5 Depression 7.5.1 Etiology7.6 Epilepsy 7.6.1 Etiology7.7 Huntington's Disease 7.7.1 Etiology7.8 Hydrocephalus 7.8.1 Etiology7.9 Multiple Sclerosis 7.9.1 Etiology7.10 Myasthenia Gravis 7.10.1 Etiology7.11 Parkinson's Disease 7.11.1 Etiology7.12 Schizophrenia 7.12.1 EtiologyExhibit 7-1: 2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender Exhibit 7-2: 2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender Exhibit 7-3: Italy and Europe, Alzheimer's Disease, Comparative Incidence and Prevalence Exhibit 7-4: Italy and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence Exhibit 7-5: Italy and Europe, Bipolar Disorder, Comparative Incidence and Prevalence Exhibit 7-6: Italy and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence Exhibit 7-7: Italy and Europe, Stroke, Comparative Incidence and Prevalence Exhibit 7-8: Italy and Europe, Depression, Comparative Prevalence Exhibit 7-9: Italy and Europe, Epilepsy, Comparative Incidence and Prevalence Exhibit 7-10: Italy and Europe, Huntington's Disease, Comparative Incidence and Prevalence Exhibit 7-11: Italy and Europe, Hydrocephalus, Comparative Incidence and Prevalence Exhibit 7-12: Italy and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence Exhibit 7-13: Italy and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence Exhibit 7-14: Italy and Europe, Parkinson's Disease, Comparative Incidence and Prevalence Exhibit 7-15: Italy and Europe, Schizophrenia, Comparative Incidence and Prevalence 8. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA 8.1 Cataracts 8.1.1 Etiology8.2 Glaucoma 8.2.1 EtiologyExhibit 8-1: Italy and Europe, Cataracts, Comparative Incidence and Prevalence Exhibit 8-2: Italy and Europe, Glaucoma, Comparative Incidence and Prevalence 9. REPRODUCTIVE AND GENITOURINARY DISORDERS 9.1 Benign Prostatic Hyperplasia 9.1.1 Etiology9.2 Endometriosis 9.2.1 Etiology9.3 Erectile Dysfunction 9.3.1 Etiology9.4 Infertility 9.4.1 Etiology9.5 Urinary Incontinence 9.5.1 EtiologyExhibit 9-1: 2010, Europe, Benign Prostatic Hyperplasia, Incidence, by Age Exhibit 9-2: Italy and Europe, Benign Prostatic Hyperplasia, Comparative Incidence and Prevalence Exhibit 9-3: Italy and Europe, Endometriosis, Comparative Prevalence Exhibit 9-4: Italy and Europe, Erectile Dysfunction, Comparative Incidence and Prevalence Exhibit 9-5: Italy and Europe, Infertility, Comparative Incidence and Prevalence Exhibit 9-6: Italy and Europe, Urinary Incontinence, Comparative Incidence and Prevalence 10. RESPIRATORY DISORDERS 10.1 Acute Respiratory Distress Syndrome 10.1.1 Etiology10.2 Apnea 10.2.1 Etiology10.3 Asthma 10.3.1 Etiology10.4 Cystic Fibrosis 10.4.1 Etiology10.5 Emphysema 10.5.1 Etiology10.6 Pneumothorax 10.6.1 Etiology10.7 Respiratory Failure 10.7.1 Etiology10.8 Restrictive Lung Disease 10.8.1 EtiologyExhibit 10-1: Italy and Europe, Acute Respiratory Distress Syndrome, Comparative Incidence Exhibit 10-2: Italy and Europe, Apnea, Comparative Incidence and Prevalence Exhibit 10-3: Italy and Europe, Asthma, Comparative Incidence and Prevalence Exhibit 10-4: Italy and Europe, Cystic Fibrosis, Comparative Incidence and Prevalence Exhibit 10-5: Italy and Europe, Emphysema, Comparative Prevalence Exhibit 10-6: Italy and Europe, Pneumothorax, Comparative Incidence and Prevalence Exhibit 10-7: Italy and Europe, Respiratory Failure, Comparative Incidence and Prevalence Exhibit 10-8: Italy and Europe, Restrictive Lung Disease, Comparative Incidence and Prevalence 11. WOUNDS 11.1 Diabetic Ulcers 11.1.1 Etiology11.2 Pressure Ulcers 11.2.1 Etiology11.3 Surgical Wounds 11.3.1 Etiology11.4 Traumatic Wounds 11.4.1 BurnsExhibit 11-1: Italy and Europe, Diabetic Ulcers, Comparative Incidence and Prevalence Exhibit 11-2: Italy and Europe, Pressure Ulcers, Comparative Incidence and Prevalence Exhibit 11-3: Italy and Europe, Surgical Wounds, Comparative Incidence Exhibit 11-4: Classification of Burns, by Mechanism of Injury Exhibit 11-5: Italy and Europe, Burns and Acute Traumatic Injury, Comparative Incidence 12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS 12.1 Chronic Bronchitis 12.1.1 Etiology12.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 12.2.1 Etiology12.3 Pneumonia 12.3.1 Etiology12.4 Transmissible Spongiform Encephalopathies 12.4.1 Etiology12.5 Tuberculosis 12.5.1 EtiologyExhibit 12-1: Italy and Europe, Chronic Bronchitis, Comparative Prevalence Exhibit 12-2: Acquired Immune Deficiency Syndrome, Indicator Diseases Exhibit 12-3: Italy and Europe, Human Immunodeficiency Virus, Comparative Incidence and Prevalence Exhibit 12-4: Italy and Europe, Acquired Immune Deficiency Syndrome, Comparative Incidence and Prevalence Exhibit 12-5: Italy and Europe, Pneumonia, Comparative Incidence Exhibit 12-6: Italy and Europe, Transmissible Spongiform Encephalopathies, Comparative Incidence Exhibit 12-7: Italy and Europe, Tuberculosis, Comparative Incidence and Prevalence Spain INTRODUCTION 1. EUROPEAN HEALTHCARE OVERVIEW 1.1 Healthcare Spending 1.2 Healthcare Facilities and Providers 1.3 Reimbursement Structures and Common Market Directives 1.4 Selected National Healthcare Profiles for Spain 1.4.1 Healthcare Organization and ReformExhibit 1-1: European Healthcare Expenditures as a Percentage of Gross Domestic Product, Selected Countries, 2002-2008 Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020 Exhibit 1-3: Classification of European Healthcare Providers Exhibit 1-4: Healthcare Providers within the European Economy Exhibit 1-5: Average Hospital Length of Stay, Acute Care, Selected Countries, 2002-2008 Exhibit 1-6: European Union, Medical Devices Risk Classification System Exhibit 1-7: Spain, Selected National Healthcare Statistics 2. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA 2.1 Anemia 2.1.1 Iron Deficiency Anemia2.2 Hemophilia 2.2.1 EtiologyExhibit 2-1: Europe, Estimated Prevalence of Anemia, by Age and Gender Exhibit 2-2: Spain and Europe, Iron Deficiency Anemia, Comparative Incidence and Prevalence Exhibit 2-3: Spain and Europe, Sickle Cell Anemia, Comparative Incidence and Prevalence Exhibit 2-4: Spain and Europe, Thalassemia, Comparative Prevalence Exhibit 2-5: Spain and Europe, Hemophilia, Comparative Incidence and Prevalence 3. CANCER 3.1 Bladder Cancer 3.1.1 Etiology3.2 Brain Tumors 3.2.1 Etiology3.3 Breast Cancer 3.3.1 Etiology3.4 Cervical/Uterine Cancer 3.4.1 Etiology3.5 Colon/Rectal Cancer 3.5.1 Etiology3.6 Esophageal Cancer 3.6.1 Etiology3.7 Kidney/Urothelial Cancer 3.7.1 Etiology3.8 Leukemia 3.8.1 Etiology3.9 Lung Cancer 3.9.1 Etiology3.10 Lymphoma 3.10.1 Etiology3.11 Melanoma 3.11.1 Etiology3.12 Oral Cancer 3.12.1 Etiology3.13 Ovarian Cancer 3.13.1 Etiology3.14 Pancreatic Cancer 3.14.1 Etiology3.15 Prostate Cancer 3.15.1 Etiology3.16 Stomach Cancer 3.16.1 Etiology3.17 Testicular Cancer 3.17.1 EtiologyExhibit 3-1: Spain and Europe, Bladder Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-2: Spain and Europe, Brain Tumors, Comparative Incidence, by Gender Exhibit 3-3: Spain and Europe, Breast Cancer, Comparative Incidence and Mortality Exhibit 3-4: Spain and Europe, Cervical/Uterine Cancer, Comparative Incidence and Mortality Exhibit 3-5: Spain and Europe, Colon/Rectal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-6: Spain and Europe, Esophageal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-7: Spain and Europe, Kidney/Urothelial Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-8: Spain and Europe, Leukemia, Comparative Incidence and Mortality, by Gender Exhibit 3-9: Spain and Europe, Lung Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-10: Spain and Europe, Lymphoma, Comparative Incidence and Mortality, by Gender Exhibit 3-11: Spain and Europe, Melanoma, Comparative Incidence and Mortality, by Gender Exhibit 3-12: Spain and Europe, Oral Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-13: Spain and Europe, Ovarian Cancer, Comparative Incidence and Mortality Exhibit 3-14: Spain and Europe, Pancreatic Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-15: Spain and Europe, Prostate Cancer, Comparative Incidence and Mortality Exhibit 3-16: Spain and Europe, Stomach Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-17: Spain and Europe, Testicular Cancer, Comparative Incidence and Mortality 4. CARDIOVASCULAR DISORDERS 4.1 Cardiac Arrhythmia 4.1.1 Etiology4.2 Heart Failure 4.2.1 Etiology4.3 Heart Valve Disorders 4.3.1 Etiology4.4 Hypertension 4.4.1 Etiology4.5 Vascular Disorders 4.5.1 AneurysmsExhibit 4-1: Spain and Europe, Atrial Fibrillation, Comparative Incidence and Prevalence Exhibit 4-2: Spain and Europe, Atrial Flutter, Comparative Incidence and Prevalence Exhibit 4-3: Spain and Europe, Supraventricular Tachycardia, Comparative Incidence and Prevalence Exhibit 4-4: Spain and Europe, Heart Failure, Comparative Incidence and Prevalence, by Gender Exhibit 4-5: Spain and Europe, Heart Valve Disorders, Comparative Incidence and Prevalence, by Gender Exhibit 4-6: Spain and Europe, Hypertension, Comparative Incidence and Prevalence Exhibit 4-7: Spain and Europe, Aneurysms, Comparative Incidence and Prevalence Exhibit 4-8: Standard Angina Pectoris Classification Exhibit 4-9: Spain and Europe, Angina Pectoris, Comparative Incidence and Prevalence, by Gender Exhibit 4-10: Spain and Europe, Hypercholesteremia, Comparative Prevalence, by Gender and Selected Country Exhibit 4-11: Spain and Europe, Myocardial Infarction, Comparative Incidence and Prevalence, by Gender Exhibit 4-12: Spain and Europe, Peripheral Vascular Disease, Comparative Incidence and Prevalence 5. METABOLIC DISORDERS 5.1 Cholelithiasis 5.1.1 Etiology5.2 Chronic Kidney Disease/End-Stage Renal Disease 5.2.1 Etiology5.3 Diabetes 5.3.1 Etiology5.4 Urolithiasis 5.4.1 EtiologyExhibit 5-1: Spain and Europe, Cholelithiasis, Comparative Incidence and Prevalence Exhibit 5-2: Spain and Europe, Chronic Kidney Disease, Comparative Incidence and Prevalence, by Gender Exhibit 5-3: Spain and Europe, Diabetes, Comparative Incidence, by Gender Exhibit 5-4: Spain and Europe, Diabetes, Comparative Prevalence, by Share of Population Exhibit 5-5: Spain and Europe, Diabetes, Comparative Prevalence, by Gender and Age Group Exhibit 5-6: Spain and Europe, Urolithiasis, Comparative Incidence and Prevalence 6. MUSCULOSKELETAL DISORDERS 6.1 Arthritis 6.1.1 Etiology6.2 Carpal Tunnel Syndrome 6.2.1 Etiology6.3 Meniscal and Ligament/Tendon Injuries 6.3.1 Etiology6.4 Duchenne Muscular Dystrophy 6.4.1 Etiology6.5 Osteoporosis 6.5.1 EtiologyExhibit 6-1: Spain and Europe, Rheumatoid Arthritis, Comparative Incidence and Prevalence Exhibit 6-2: Spain and Europe, Osteoarthritis of the Knee, Comparative Incidence and Prevalence Exhibit 6-3: Spain and Europe, Osteoarthritis of the Hip, Comparative Incidence and Prevalence Exhibit 6-4: Spain and Europe, Carpal Tunnel Syndrome, Comparative Incidence and Prevalence Exhibit 6-5: Spain and Europe, Meniscal and Ligament/Tendon Injuries of the Knee, Comparative Incidence and Prevalence Exhibit 6-6: Spain and Europe, Duchenne Muscular Dystrophy, Comparative Incidence and Prevalence Exhibit 6-7: Spain and Europe, Osteoporosis, Comparative Incidence and Prevalence 7. NEUROLOGIC ANDPSYCHIATRIC DISORDERS 7.1 Alzheimer's Disease and Dementia 7.1.1 Etiology7.2 Amyotrophic Lateral Sclerosis 7.2.1 Etiology7.3 Bipolar Disorder 7.3.1 Etiology7.4 Cerebrovascular Disorders 7.4.1 Arteriovenous Malformation7.5 Depression 7.5.1 Etiology7.6 Epilepsy 7.6.1 Etiology7.7 Huntington's Disease 7.7.1 Etiology7.8 Hydrocephalus 7.8.1 Etiology7.9 Multiple Sclerosis 7.9.1 Etiology7.10 Myasthenia Gravis 7.10.1 Etiology7.11 Parkinson's Disease 7.11.1 Etiology7.12 Schizophrenia 7.12.1 EtiologyExhibit 7-1: 2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender Exhibit 7-2: 2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender Exhibit 7-3: Spain and Europe, Alzheimer's Disease, Comparative Incidence and Prevalence Exhibit 7-4: Spain and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence Exhibit 7-5: Spain and Europe, Bipolar Disorder, Comparative Incidence and Prevalence Exhibit 7-6: Spain and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence Exhibit 7-7: Spain and Europe, Stroke, Comparative Incidence and Prevalence Exhibit 7-8: Spain and Europe, Depression, Comparative Prevalence Exhibit 7-9: Spain and Europe, Epilepsy, Comparative Incidence and Prevalence Exhibit 7-10: Spain and Europe, Huntington's Disease, Comparative Incidence and Prevalence Exhibit 7-11: Spain and Europe, Hydrocephalus, Comparative Incidence and Prevalence Exhibit 7-12: Spain and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence Exhibit 7-13: Spain and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence Exhibit 7-14: Spain and Europe, Parkinson's Disease, Comparative Incidence and Prevalence Exhibit 7-15: Spain and Europe, Schizophrenia, Comparative Incidence and Prevalence 8. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA 8.1 Cataracts 8.1.1 Etiology8.2 Glaucoma 8.2.1 EtiologyExhibit 8-1: Spain and Europe, Cataracts, Comparative Incidence and Prevalence Exhibit 8-2: Spain and Europe, Glaucoma, Comparative Incidence and Prevalence 9. REPRODUCTIVE AND GENITOURINARY DISORDERS 9.1 Benign Prostatic Hyperplasia 9.1.1 Etiology9.2 Endometriosis 9.2.1 Etiology9.3 Erectile Dysfunction 9.3.1 Etiology9.4 Infertility 9.4.1 Etiology9.5 Urinary Incontinence 9.5.1 EtiologyExhibit 9-1: 2010, Europe, Benign Prostatic Hyperplasia, Incidence, by Age Exhibit 9-2: Spain and Europe, Benign Prostatic Hyperplasia, Comparative Incidence and Prevalence Exhibit 9-3: Spain and Europe, Endometriosis, Comparative Prevalence Exhibit 9-4: Spain and Europe, Erectile Dysfunction, Comparative Incidence and Prevalence Exhibit 9-5: Spain and Europe, Infertility, Comparative Incidence and Prevalence Exhibit 9-6: Spain and Europe, Urinary Incontinence, Comparative Incidence and Prevalence 10. RESPIRATORY DISORDERS 10.1 Acute Respiratory Distress Syndrome 10.1.1 Etiology10.2 Apnea 10.2.1 Etiology10.3 Asthma 10.3.1 Etiology10.4 Cystic Fibrosis 10.4.1 Etiology10.5 Emphysema 10.5.1 Etiology10.6 Pneumothorax 10.6.1 Etiology10.7 Respiratory Failure 10.7.1 Etiology10.8 Restrictive Lung Disease 10.8.1 EtiologyExhibit 10-1: Spain and Europe, Acute Respiratory Distress Syndrome, Comparative Incidence Exhibit 10-2: Spain and Europe, Apnea, Comparative Incidence and Prevalence Exhibit 10-3: Spain and Europe, Asthma, Comparative Incidence and Prevalence Exhibit 10-4: Spain and Europe, Cystic Fibrosis, Comparative Incidence and Prevalence Exhibit 10-5: Spain and Europe, Emphysema, Comparative Prevalence Exhibit 10-6: Spain and Europe, Pneumothorax, Comparative Incidence and Prevalence Exhibit 10-7: Spain and Europe, Respiratory Failure, Comparative Incidence and Prevalence Exhibit 10-8: Spain and Europe, Restrictive Lung Disease, Comparative Incidence and Prevalence 11. WOUNDS 11.1 Diabetic Ulcers 11.1.1 Etiology11.2 Pressure Ulcers 11.2.1 Etiology11.3 Surgical Wounds 11.3.1 Etiology11.4 Traumatic Wounds 11.4.1 BurnsExhibit 11-1: Spain and Europe, Diabetic Ulcers, Comparative Incidence and Prevalence Exhibit 11-2: Spain and Europe, Pressure Ulcers, Comparative Incidence and Prevalence Exhibit 11-3: Spain and Europe, Surgical Wounds, Comparative Incidence Exhibit 11-4: Classification of Burns, by Mechanism of Injury Exhibit 11-5: Spain and Europe, Burns and Acute Traumatic Injury, Comparative Incidence 12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS 12.1 Chronic Bronchitis 12.1.1 Etiology12.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 12.2.1 Etiology12.3 Pneumonia 12.3.1 Etiology12.4 Transmissible Spongiform Encephalopathies 12.4.1 Etiology12.5 Tuberculosis 12.5.1 EtiologyExhibit 12-1: Spain and Europe, Chronic Bronchitis, Comparative Prevalence Exhibit 12-2: Acquired Immune Deficiency Syndrome, Indicator Diseases Exhibit 12-3: Spain and Europe, Human Immunodeficiency Virus, Comparative Incidence and Prevalence Exhibit 12-4: Spain and Europe, Acquired Immune Deficiency Syndrome, Comparative Incidence and Prevalence Exhibit 12-5: Spain and Europe, Pneumonia, Comparative Incidence Exhibit 12-6: Spain and Europe, Transmissible Spongiform Encephalopathies, Comparative Incidence Exhibit 12-7: Spain and Europe, Tuberculosis, Comparative Incidence and Prevalence United Kingdom INTRODUCTION 1. EUROPEAN HEALTHCARE OVERVIEW 1.1 Healthcare Spending 1.2 Healthcare Facilities and Providers 1.3 Reimbursement Structures and Common Market Directives 1.4 Selected National Healthcare Profiles for United Kingdom 1.4.1 Healthcare Organization and ReformExhibit 1-1: European Healthcare Expenditures as a Percentage of Gross Domestic Product, Selected Countries, 2002-2008 Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020 Exhibit 1-3: Classification of European Healthcare Providers Exhibit 1-4: Healthcare Providers within the European Economy Exhibit 1-5: Average Hospital Length of Stay, Acute Care, Selected Countries, 2002-2008 Exhibit 1-6: European Union, Medical Devices Risk Classification System Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics 2. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA 2.1 Anemia 2.1.1 Iron Deficiency Anemia2.2 Hemophilia 2.2.1 EtiologyExhibit 2-1: Europe, Estimated Prevalence of Anemia, by Age and Gender Exhibit 2-2: United Kingdom and Europe, Iron Deficiency Anemia, Comparative Incidence and Prevalence Exhibit 2-3: United Kingdom and Europe, Sickle Cell Anemia, Comparative Incidence and Prevalence Exhibit 2-4: United Kingdom and Europe, Thalassemia, Comparative Prevalence Exhibit 2-5: United Kingdom and Europe, Hemophilia, Comparative Incidence and Prevalence 3. CANCER 3.1 Bladder Cancer 3.1.1 Etiology3.2 Brain Tumors 3.2.1 Etiology3.3 Breast Cancer 3.3.1 Etiology3.4 Cervical/Uterine Cancer 3.4.1 Etiology3.5 Colon/Rectal Cancer 3.5.1 Etiology3.6 Esophageal Cancer 3.6.1 Etiology3.7 Kidney/Urothelial Cancer 3.7.1 Etiology3.8 Leukemia 3.8.1 Etiology3.9 Lung Cancer 3.9.1 Etiology3.10 Lymphoma 3.10.1 Etiology3.11 Melanoma 3.11.1 Etiology3.12 Oral Cancer 3.12.1 Etiology3.13 Ovarian Cancer 3.13.1 Etiology3.14 Pancreatic Cancer 3.14.1 Etiology3.15 Prostate Cancer 3.15.1 Etiology3.16 Stomach Cancer 3.16.1 Etiology3.17 Testicular Cancer 3.17.1 EtiologyExhibit 3-1: United Kingdom and Europe, Bladder Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-2: United Kingdom and Europe, Brain Tumors, Comparative Incidence, by Gender Exhibit 3-3: United Kingdom and Europe, Breast Cancer, Comparative Incidence and Mortality Exhibit 3-4: United Kingdom and Europe, Cervical/Uterine Cancer, Comparative Incidence and Mortality Exhibit 3-5: United Kingdom and Europe, Colon/Rectal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-6: United Kingdom and Europe, Esophageal Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-7: United Kingdom and Europe, Kidney/Urothelial Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-8: United Kingdom and Europe, Leukemia, Comparative Incidence and Mortality, by Gender Exhibit 3-9: United Kingdom and Europe, Lung Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-10: United Kingdom and Europe, Lymphoma, Comparative Incidence and Mortality, by Gender Exhibit 3-11: United Kingdom and Europe, Melanoma, Comparative Incidence and Mortality, by Gender Exhibit 3-12: United Kingdom and Europe, Oral Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-13: United Kingdom and Europe, Ovarian Cancer, Comparative Incidence and Mortality Exhibit 3-14: United Kingdom and Europe, Pancreatic Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-15: United Kingdom and Europe, Prostate Cancer, Comparative Incidence and Mortality Exhibit 3-16: United Kingdom and Europe, Stomach Cancer, Comparative Incidence and Mortality, by Gender Exhibit 3-17: United Kingdom and Europe, Testicular Cancer, Comparative Incidence and Mortality 4. CARDIOVASCULAR DISORDERS 4.1 Cardiac Arrhythmia 4.1.1 Etiology4.2 Heart Failure 4.2.1 Etiology4.3 Heart Valve Disorders 4.3.1 Etiology4.4 Hypertension 4.4.1 Etiology4.5 Vascular Disorders 4.5.1 AneurysmsExhibit 4-1: United Kingdom and Europe, Atrial Fibrillation, Comparative Incidence and Prevalence Exhibit 4-2: United Kingdom and Europe, Atrial Flutter, Comparative Incidence and Prevalence Exhibit 4-3: United Kingdom and Europe, Supraventricular Tachycardia, Comparative Incidence and Prevalence Exhibit 4-4: United Kingdom and Europe, Heart Failure, Comparative Incidence and Prevalence, by Gender Exhibit 4-5: United Kingdom and Europe, Heart Valve Disorders, Comparative Incidence and Prevalence, by Gender Exhibit 4-6: United Kingdom and Europe, Hypertension, Comparative Incidence and Prevalence Exhibit 4-7: United Kingdom and Europe, Aneurysms, Comparative Incidence and Prevalence Exhibit 4-8: Standard Angina Pectoris Classification Exhibit 4-9: United Kingdom and Europe, Angina Pectoris, Comparative Incidence and Prevalence, by Gender Exhibit 4-10: United Kingdom and Europe, Hypercholesteremia, Comparative Prevalence, by Gender and Selected Country Exhibit 4-11: United Kingdom and Europe, Myocardial Infarction, Comparative Incidence and Prevalence, by Gender Exhibit 4-12: United Kingdom and Europe, Peripheral Vascular Disease, Comparative Incidence and Prevalence 5. METABOLIC DISORDERS 5.1 Cholelithiasis 5.1.1 Etiology5.2 Chronic Kidney Disease/End-Stage Renal Disease 5.2.1 Etiology5.3 Diabetes 5.3.1 Etiology5.4 Urolithiasis 5.4.1 EtiologyExhibit 5-1: United Kingdom and Europe, Cholelithiasis, Comparative Incidence and Prevalence Exhibit 5-2: United Kingdom and Europe, Chronic Kidney Disease, Comparative Incidence and Prevalence, by Gender Exhibit 5-3: United Kingdom and Europe, Diabetes, Comparative Incidence, by Gender Exhibit 5-4: United Kingdom and Europe, Diabetes, Comparative Prevalence, by Share of Population Exhibit 5-5: United Kingdom and Europe, Diabetes, Comparative Prevalence, by Gender and Age Group Exhibit 5-6: United Kingdom and Europe, Urolithiasis, Comparative Incidence and Prevalence 6. MUSCULOSKELETAL DISORDERS 6.1 Arthritis 6.1.1 Etiology6.2 Carpal Tunnel Syndrome 6.2.1 Etiology6.3 Meniscal and Ligament/Tendon Injuries 6.3.1 Etiology6.4 Duchenne Muscular Dystrophy 6.4.1 Etiology6.5 Osteoporosis 6.5.1 EtiologyExhibit 6-1: United Kingdom and Europe, Rheumatoid Arthritis, Comparative Incidence and Prevalence Exhibit 6-2: United Kingdom and Europe, Osteoarthritis of the Knee, Comparative Incidence and Prevalence Exhibit 6-3: United Kingdom and Europe, Osteoarthritis of the Hip, Comparative Incidence and Prevalence Exhibit 6-4: United Kingdom and Europe, Carpal Tunnel Syndrome, Comparative Incidence and Prevalence Exhibit 6-5: United Kingdom and Europe, Meniscal and Ligament/Tendon Injuries of the Knee, Comparative Incidence and Prevalence Exhibit 6-6: United Kingdom and Europe, Duchenne Muscular Dystrophy, Comparative Incidence and Prevalence Exhibit 6-7: United Kingdom and Europe, Osteoporosis, Comparative Incidence and Prevalence 7. NEUROLOGIC ANDPSYCHIATRIC DISORDERS 7.1 Alzheimer's Disease and Dementia 7.1.1 Etiology7.2 Amyotrophic Lateral Sclerosis 7.2.1 Etiology7.3 Bipolar Disorder 7.3.1 Etiology7.4 Cerebrovascular Disorders 7.4.1 Arteriovenous Malformation7.5 Depression 7.5.1 Etiology7.6 Epilepsy 7.6.1 Etiology7.7 Huntington's Disease 7.7.1 Etiology7.8 Hydrocephalus 7.8.1 Etiology7.9 Multiple Sclerosis 7.9.1 Etiology7.10 Myasthenia Gravis 7.10.1 Etiology7.11 Parkinson's Disease 7.11.1 Etiology7.12 Schizophrenia 7.12.1 EtiologyExhibit 7-1: 2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender Exhibit 7-2: 2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender Exhibit 7-3: United Kingdom and Europe, Alzheimer's Disease, Comparative Incidence and Prevalence Exhibit 7-4: United Kingdom and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence Exhibit 7-5: United Kingdom and Europe, Bipolar Disorder, Comparative Incidence and Prevalence Exhibit 7-6: United Kingdom and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence Exhibit 7-7: United Kingdom and Europe, Stroke, Comparative Incidence and Prevalence Exhibit 7-8: United Kingdom and Europe, Depression, Comparative Prevalence Exhibit 7-9: United Kingdom and Europe, Epilepsy, Comparative Incidence and Prevalence Exhibit 7-10: United Kingdom and Europe, Huntington's Disease, Comparative Incidence and Prevalence Exhibit 7-11: United Kingdom and Europe, Hydrocephalus, Comparative Incidence and Prevalence Exhibit 7-12: United Kingdom and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence Exhibit 7-13: United Kingdom and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence Exhibit 7-14: United Kingdom and Europe, Parkinson's Disease, Comparative Incidence and Prevalence Exhibit 7-15: United Kingdom and Europe, Schizophrenia, Comparative Incidence and Prevalence 8. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA 8.1 Cataracts 8.1.1 Etiology8.2 Glaucoma 8.2.1 EtiologyExhibit 8-1: United Kingdom and Europe, Cataracts, Comparative Incidence and Prevalence Exhibit 8-2: United Kingdom and Europe, Glaucoma, Comparative Incidence and Prevalence 9. REPRODUCTIVE AND GENITOURINARY DISORDERS 9.1 Benign Prostatic Hyperplasia 9.1.1 Etiology9.2 Endometriosis 9.2.1 Etiology9.3 Erectile Dysfunction 9.3.1 Etiology9.4 Infertility 9.4.1 Etiology9.5 Urinary Incontinence 9.5.1 EtiologyExhibit 9-1: 2010, Europe, Benign Prostatic Hyperplasia, Incidence, by Age Exhibit 9-2: United Kingdom and Europe, Benign Prostatic Hyperplasia, Comparative Incidence and Prevalence Exhibit 9-3: United Kingdom and Europe, Endometriosis, Comparative Prevalence Exhibit 9-4: United Kingdom and Europe, Erectile Dysfunction, Comparative Incidence and Prevalence Exhibit 9-5: United Kingdom and Europe, Infertility, Comparative Incidence and Prevalence Exhibit 9-6: United Kingdom and Europe, Urinary Incontinence, Comparative Incidence and Prevalence 10. RESPIRATORY DISORDERS 10.1 Acute Respiratory Distress Syndrome 10.1.1 Etiology10.2 Apnea 10.2.1 Etiology10.3 Asthma 10.3.1 Etiology10.4 Cystic Fibrosis 10.4.1 Etiology10.5 Emphysema 10.5.1 Etiology10.6 Pneumothorax 10.6.1 Etiology10.7 Respiratory Failure 10.7.1 Etiology10.8 Restrictive Lung Disease 10.8.1 EtiologyExhibit 10-1: United Kingdom and Europe, Acute Respiratory Distress Syndrome, Comparative Incidence Exhibit 10-2: United Kingdom and Europe, Apnea, Comparative Incidence and Prevalence Exhibit 10-3: United Kingdom and Europe, Asthma, Comparative Incidence and Prevalence Exhibit 10-4: United Kingdom and Europe, Cystic Fibrosis, Comparative Incidence and Prevalence Exhibit 10-5: United Kingdom and Europe, Emphysema, Comparative Prevalence Exhibit 10-6: United Kingdom and Europe, Pneumothorax, Comparative Incidence and Prevalence Exhibit 10-7: United Kingdom and Europe, Respiratory Failure, Comparative Incidence and Prevalence Exhibit 10-8: United Kingdom and Europe, Restrictive Lung Disease, Comparative Incidence and Prevalence 11. WOUNDS 11.1 Diabetic Ulcers 11.1.1 Etiology11.2 Pressure Ulcers 11.2.1 Etiology11.3 Surgical Wounds 11.3.1 Etiology11.4 Traumatic Wounds 11.4.1 BurnsExhibit 11-1: United Kingdom and Europe, Diabetic Ulcers, Comparative Incidence and Prevalence Exhibit 11-2: United Kingdom and Europe, Pressure Ulcers, Comparative Incidence and Prevalence Exhibit 11-3: United Kingdom and Europe, Surgical Wounds, Comparative Incidence Exhibit 11-4: Classification of Burns, by Mechanism of Injury Exhibit 11-5: United Kingdom and Europe, Burns and Acute Traumatic Injury, Comparative Incidence 12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS 12.1 Chronic Bronchitis 12.1.1 Etiology12.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 12.2.1 Etiology12.3 Pneumonia 12.3.1 Etiology12.4 Transmissible Spongiform Encephalopathies 12.4.1 Etiology12.5 Tuberculosis 12.5.1 EtiologyExhibit 12-1: United Kingdom and Europe, Chronic Bronchitis, Comparative Prevalence Exhibit 12-2: Acquired Immune Deficiency Syndrome, Indicator Diseases Exhibit 12-3: United Kingdom and Europe, Human Immunodeficiency Virus, Comparative Incidence and Prevalence Exhibit 12-4: United Kingdom and Europe, Acquired Immune Deficiency Syndrome, Comparative Incidence and Prevalence Exhibit 12-5: United Kingdom and Europe, Pneumonia, Comparative Incidence Exhibit 12-6: United Kingdom and Europe, Transmissible Spongiform Encephalopathies, Comparative Incidence Exhibit 12-7: United Kingdom and Europe, Tuberculosis, Comparative Incidence and Prevalence Due to this report being strictly related to Disease Incidence and Prevalence data, the report will not have a company listing. Publisher: Medtech Insight |
Новини
03.03.2023 Науково доведено: через смартфони ви можете старіти швидше
24.02.2023 Стимуляція спинного мозку відновлює постінсультну функцію рук 17.02.2023 Вчені відкрили здатність жирної їжі руйнувати мозок 10.02.2023 В Індії розробили неінвазивний тест, який використовує штучний інтелект для виявлення раку молочної залози 01.02.2023 Як спостереження за світанками та заходами сонця впливає на здоров'я – вчені 25.01.2023 Аналіз крові для ранньої діагностики хвороби Альцгеймера розробили вчені 18.01.2023 Людина з серцем свині. Пацієнту вперше пересадили серце тварини 11.01.2023 Вчені пояснили, чому оливкову олію варто пити ложками 21.11.2022 Вчені виявили ще одну причину високого ризику атеросклерозу 18.11.2022 Імплантована помпа доставила протиракові ліки у пухлини мозку 16.11.2022 Шум вночі може бути причиною безсоння та серцево-судинних захворювань 14.11.2022 ЩО ТРЕБА ЗНАТИ ПРО ЦУКРОВИЙ ДІАБЕТ: ТИПИ, СИМПТОМИ, УСКЛАДНЕННЯ 11.11.2022 Виявилося, в епідемії ожиріння винен лише один тип їжі 09.11.2022 Проказа: давня хвороба, здатна регенерувати органи 07.11.2022 "Чарівні гриби" можуть лікувати важку депресію 04.11.2022 Нове випробування пропонує переваги CV з EPA: RESPECT-EPA 02.11.2022 Майже 500 українських медиків завершили навчання з тактичної медицини 01.11.2022 Чи можна людям з діабетом пити алкоголь 31.10.2022 Знайдено овоч, здатний знизити цукор у крові відразу на 20% 28.10.2022 Людська печінка може працювати 100 років |